News & Tweets

Apostle is elected into the StartX Accelerator Program (Summer 2018 session), one of the most pretigeous accelerator programs in Silicon Valley. read more

Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. read more

Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. read more

Apostle Inc is pleased to announce the signing of an agreement with Filgen Inc to supply and distribute Apostle’s technological products exclusively in Japan. read more

Apostle won the Second Place in the Final of North America Region, CACSC，(Create@AlibabaCloud Startup Contest). Over 300 startups from North America have competed in CACSC, and 13 entered the final. read more

Apostle Inc is pleased to announce the appointment of Dean W. Felsher, MD, PhD as a new member to its Scientific Advisory Board. Dr. Felsher is Professor of Medicine in Departments of Oncology and Pathology at Stanford University School of Medicine. He is Director of Stanford Translational Research and Applied Medicine (TRAM) as well as Director of Oncology Research, Division of Oncology at Stanford. read more

Apostle Inc is selected into the Amazon Web Service (AWS) Activate Program. The AWS Activate Portfolio Package received by Apostle includes a one-year AWS Gold Premium Support and a two-year AWS usage credit. read more

Forbes China named Apostle Inc’s co-Founder and VP of Chemistry, Bo Zhang, PhD, as one of the most brilliant young entrepreneurs in its annual “30 Under 30 China” list in the category of healthcare and science. read more

Apostle Inc is pleased to announce the appointment of William Dai, MBA as a new member to its Board of Directors, and Charles Cantor, PhD and Hongyu Zhao, PhD as new members to its Advisory Board. read more

Apostle Inc today led a round-table discussion at the 7th Asia Pharma R&D Leaders 2017, held in Shanghai, China. read more

Apostle CEO David Ge is invited to be on the Advisory Board of the 13th Annual Biomarkers Congress, organized by the Oxford Global and to be held in February 2018 in Manchester, UK. read more

Apostle Inc, a biotechnology company developing an AI-enabled nanoDiagnostics (AID) technology for early cancer detection, is founded in the Silicon Valley. read more